Sonomax licenses V4 technology to Creare

NewsGuard 100/100 Score

U.S. based Research & Development undertake research for US Navy

Sonomax Technologies Inc. (SHH:TSX Venture) is pleased to announce that it has signed its first licensing deal whereby its groundbreaking V4 technology has been licensed to Creare Inc. (Creare) for use in a Research and Development (R&D) project being executed on behalf of the United States Navy. If the synergy of Creare and Sonomax produces a product or technology that can be commercialized, then it is agreed that both parties will work together to explore opportunities to jointly license the combined technology.

This R&D license has been fixed at $10,000 USD and has a term of one year.

Nick Laperle, President and CEO of Sonomax Technologies Inc., commented that, "we are absolutely thrilled that our first licensing arrangement is with such a competent and established R&D group, like Creare. What is more, our relationship with them goes back over two years and they have shown themselves to be a good and helpful organization that has more than once offered guidance and advice to us as we build our licensing business. I believe that we will benefit immensely from their experience. I look forward to the synergies our respective technologies and personnel can create together.

Source:

SONOMAX TECHNOLOGIES INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals lifestyle factors boosting IVF success